Citigroup »

Orchard Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Orchard Therapeutics shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Orchard Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orchard Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orchard Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8k 110 16.45
2023-09-30 $853 110 7.76
2023-03-31 $901k 168k 5.37